Share this post on:

Name:

Tildrakizumab Biosimilar, Anti-IL23A

Host species:

Humanized

Species reactivity:

Human

Form:

solution

Storage buffer:

0.01M PBS, pH 7.4.

Concentration:

1 mg/ml

Purity:

>95% by SDS-PAGE.=VLOOKUP

F363,[1]Worksheet!$A:$V,22,0:

Isotype:

IgG1-kappa

Applications:

Biosimilar

For research use only. We do not sell to patients.

Target:

SGRF, IL-23-A, IL-23 subunit alpha, Interleukin-23 subunit p19, IL23A, Interleukin-23 subunit alpha, IL-23p19

Purification:

Protein A or G purified from cell culture supernatant.

Endotoxin level:

Please contact with the lab for this information.

Expression system:

MammalianQ9NPF7https://www.ncbi.nlm.nih.gov/protein/Q9NPF7

Stability and Storage:

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4C short term

1-2 weeks:

.Store at -20 C 12 months. Store at -80C long term.

Alternative Names:

MK-3222, SCH900222, CAS: 1326244-10-3Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HSP70 Antibody (YA728)
Phospho-Acetyl Coenzyme A Carboxylase (Ser79) Antibody
IL-6 Antibody (YA724): IL-6 Antibody (YA724) is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to IL-6. It can be used for WB,IHC-P,ICC,ELISA assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: signsin1dayinc